The Nasdaq Rule Is Approved: Build the Evidence Trail Before a Deficiency Notice

A continued-listing problem rarely begins with the deficiency notice. It begins months earlier, when nobody can reconstruct which metric was watched, who reviewed it, or why management decided the risk was tolerable.

Nasdaq has received approval for a new continued-listing requirement tied to a minimum Market Value of Listed Securities of $5 million. For smaller issuers, the practical response is not another spreadsheet that goes stale. It is an evidence trail that connects the metric, the review, the decision, and the person accountable for escalation.

This article addresses operational readiness, not legal advice. The rule, its effective date, transition provisions, and application to a specific issuer need legal review before publishing or implementation.

Start with the question a deficiency notice will raise

When a listing metric becomes a problem, management will need more than a current calculation. The harder questions are historical:

• When was the metric first monitored?

• What source data supported each calculation?

• Who reviewed the result?

• What trend or threshold triggered escalation?

• Which remediation options were considered?

• Who approved the selected response?

A board packet, filing, or email may contain pieces of the answer. The risk is that those pieces cannot be assembled quickly, or that the record shows measurement without an accountable decision.

Build the trail around four connected records

1. The metric record

Define the listing metric precisely, including its source, calculation date, responsible owner, and any assumptions. Preserve the underlying market and capitalization data used in the calculation rather than recording only the conclusion.

2. The review record

Set a recurring review cadence and document attendance, questions, exceptions, and follow-up items. A recurring calendar invitation is not evidence of review by itself; the record should show what was actually examined.

3. The escalation record

Write down the thresholds that move an issue from monitoring to management attention, counsel review, board discussion, or formal remediation. Avoid relying on informal judgment that exists only in a call or hallway conversation.

4. The decision record

For each material decision, capture the alternatives considered, the relevant facts, the owner, the approval date, and the next checkpoint. The objective is not to manufacture certainty. It is to show that management recognized the risk and acted deliberately.

Separate market data from management judgment

These are different kinds of evidence and should not be blended.

Market data supports the calculation. Management judgment explains what the calculation means for the company, what options are available, and when escalation is warranted. Keeping those layers separate makes later review faster and reduces the chance that an assumption is mistaken for a fact.

The same discipline applies to communications. A public announcement, investor presentation, or prepared response should not quietly introduce a new definition of the relevant metric. Maintain a change log for definitions, source documents, and approval status so IR can identify which version was current at the time.

Make ownership visible

Small-cap teams often assume that responsibility is shared among the CFO, legal counsel, finance, and IR. In practice, shared responsibility can mean that nobody owns the next action.

Assign one operational owner for each step:

• Finance owns the calculation and source data.

• IR owns the communication and inquiry log.

• Legal reviews regulatory interpretation and disclosure implications.

• Executive management approves remediation decisions.

• The board or its relevant committee receives defined escalations.

These assignments should be documented before a threshold is breached. Waiting until a notice arrives turns a governance exercise into a crisis exercise.

Use a monitoring log that survives turnover

A useful log does not need to be elaborate. Each entry should answer five questions: what changed, when it changed, what evidence supports it, who reviewed it, and what happens next.

FiskLabs can support this kind of operating model through a disclosure and compliance monitoring workflow that links market data, filings, announcements, review status, and executive sign-off. The value is not another alert. It is a reconstructable record that helps a small IR team move from detection to accountable action.

The standard to aim for

Do not ask whether the company has a compliance calendar. Ask whether a new CFO, director, auditor, or counsel could open the record and understand the company’s monitoring history without relying on institutional memory.

If the answer is no, the deficiency risk may have started already—not because management failed to care, but because the evidence trail was never designed.